We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Shanghai Henlius Biotech, Inc. (2696.HK) et Organon (NYSE : OGN) ont annoncé aujourd’hui que l’Agence européenne des médicaments (EMA) a validé les demandes d’autorisation de mise sur le marché...
(ビジネスワイヤ) -- シャンハイ・ヘンリウス・バイオテック(2696.HK)とオルガノン(NYSE:OGN)は、欧州医薬品庁(EMA)が、Prolia®およびXgeva ®(デノスマブ)のバイオシミラーの治験薬であるHLX14の販...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.57 | 2.81899109792 | 20.22 | 21.4399 | 20.15 | 1692719 | 20.82805916 | CS |
4 | -0.04 | -0.192030724916 | 20.83 | 21.78 | 19.82 | 1573258 | 20.72119248 | CS |
12 | 2.69 | 14.861878453 | 18.1 | 21.98 | 17.33 | 1944547 | 19.6902601 | CS |
26 | 6.84 | 49.0322580645 | 13.95 | 21.98 | 13.65 | 2445687 | 17.87653339 | CS |
52 | 0.55 | 2.71739130435 | 20.24 | 24.08 | 10.835 | 3140040 | 16.73928684 | CS |
156 | -9.06 | -30.351758794 | 29.85 | 39.475 | 10.835 | 2373844 | 23.93913599 | CS |
260 | -13.41 | -39.2105263158 | 34.2 | 39.475 | 10.835 | 2520288 | 24.51149188 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions